SmartSkin Technologies announced Martin VanTrieste has joined its board of directors to offer his unique insights on how to maximize pharmaceutical manufacturing capacity.
Ned McCoy is the hospital-backed generic pharmaceutical company’s chief operating officer and will take over from current CEO, Martin VanTrieste on June 1.